References
- S ON, L OD. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1–12. doi:https://doi.org/10.1111/obr.12229
- L. C, G vL. Inflammation and the metabolic syndrome: the tissue-specific functions of NF-κB. Trends Cell Biol. 2017;27:417–29. doi:https://doi.org/10.1016/j.tcb.2017.01.006
- GG, IO, CW. Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin Immunopathol. 2018;40:215–24. doi:https://doi.org/10.1007/s00281-017-0666-5
- KK, IO, BKP. Exercise and type 2 diabetes: focus on metabolism and inflammation. Immunol Cell Biol. 2016;94:146–50. doi:https://doi.org/10.1038/icb.2015.101
- SCJ, JC, IK, GW, MT, et al. Interleukin-6, a cytokine critical to mediation of inflammation, autoimmunity and allograft rejection: therapeutic implications of IL-6 receptor blockade. Transplantation. 2017;101:32–44. doi:https://doi.org/10.1097/TP.0000000000001452
- EM, DM. Tumor necrosis factor-α, kidney function, and hypertension. Am J Physiol Renal Physiol. 2017;313:F1005–F1008. doi:https://doi.org/10.1152/ajprenal.00535
- GF, DD, FC. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22:377–88. doi:https://doi.org/10.1038/cdd.2014.150
- Homayouni A, Amini A, Keshtiban AK, Mortazavian AM, Esazadeh K, Pourmoradian S. Resistant starch in food industry: a changing outlook for consumer and producer. Starch - Stärke. 2014;66(1–2):102–14. doi:https://doi.org/10.1002/star.201300110
- Keenan MJ, Zhou J, Hegsted M, Pelkman C, Durham HA, Coulon DB, Martin RJ. Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr. 2015;6(2):198–205. doi:https://doi.org/10.3945/an.114.007419
- YW, IO, JC, YS, RZ, et al. Effects of the resistant starch on glucose, insulin, insulin resistance, and lipid. Nutr Diabetes. 2019;9:19–86. doi:https://doi.org/10.1038/s41387-019-0086-9
- HY, YM, HB, DS, BW, et al. Meta-analysis indicates that resistant starch lowers serum total cholesterol and low-density cholesterol. Nutr Res. 2018;54:1–11.
- AA, PD, BPG, MA-J. Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial. Br J Nutr. 2015;113:321–30. doi:https://doi.org/10.1017/S0007114514003675
- BG, NN, MK, BS, MJ, et al. Is there any place for resistant starch, as alimentary prebiotic, for patients with type 2 diabetes? Complement Ther Med. 2015;23:810–5. doi:https://doi.org/10.1016/j.ctim.2015.09.005
- FE, IO, FB, IO, YR, et al. Effects of resistant starch supplementation on glucose metabolism, lipid profile, lipid peroxidation marker, and oxidative stress in overweight and obese adults: randomized, double-blind, crossover trial. Clin Nutr Res. 2019;8:318–28. doi:https://doi.org/10.7762/cnr.2019.8.4.318
- HK, BA, MG, AS, AJ. Effects of fermentable high fiber diet supplementation on gut derived and conventional nitrogenous product in patients on maintenance hemodialysis: a randomized controlled trial. Nutr Metab. 2019;16:19–343. doi:https://doi.org/10.1186/s12986-019-0343-x
- ML, IO, HT, HP, LL, et al. Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial. Hemodial Int. 2019;23:343–7. doi:https://doi.org/10.1111/hdi.12753
- PK, MAF, BS, BPG, AZ, et al. The therapeutic potential of resistant starch in modulation of insulin resistance, Endotoxemia, oxidative stress and antioxidant biomarkers in women with type 2 diabetes: a randomized controlled clinical trial. Ann Nutr Metab. 2016;68:85–93. doi:https://doi.org/10.1159/000441683
- SGS, PD, SM-A, AA, MM. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Eur J Nutr. 2019;58:629–40. doi:https://doi.org/10.1007/s00394-018-1648-7
- BU, LM, AF-K, RJ, SN, et al. Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions. Sci Rep. 2016;6:1–12. doi:https://doi.org/10.1038/srep28797
- CMP, RAB, KM, CKM, KA, et al. Effect of 12 wk of resistant starch supplementation on cardiometabolic risk factors in adults with prediabetes: a randomized controlled trial. Am J Clin Nutr. 2018;108:492–501. doi:https://doi.org/10.1093/ajcn/nqy121
- MP-M, GH, WB. African Americans may have to consume more than 12 grams a day of resistant starch to lower their risk for type 2 diabetes. J Med Food. 2010;13:999–1004. doi:https://doi.org/10.1089/jmf.2009.0195
- MS, SDN, DT, WT, JS. Evaluation of the effect of four fibers on laxation, gastrointestinal tolerance and serum markers in healthy humans. Ann Nutr Metab. 2010;56:91–8.
- Tl S, Ns P, Cd G, Th H, Tw M. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clin J Am Soc Nephrol. 2014;9:1603–10. doi:https://doi.org/10.2215/CJN.00490114
- Mj A, DS, Ps T, NO, PD, et al. A randomized placebo controlled clinical trial to determine the impact of digestion resistant starch MSPrebiotic® on glucose, insulin, and insulin resistance in elderly and mid-age adults. Front Med. 2018;4. doi:https://doi.org/10.3389/fmed.2017.00260
- YM, HB, QY, JY, LZ, et al. High-resistant starch, low-protein flour intervention on patients with early type 2 diabetic nephropathy: a randomized trial. J Ren Nutr. 2019;29:386–93. doi:https://doi.org/10.1053/j.jrn.2018.12.005
- ME, JAK, RA, BRP, MBS-P, et al. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial. Food Funct. 2018;9:6508–16. doi:https://doi.org/10.1039/c8fo01876f
- Jh K, Jk P, Hi K, Oy K, Dy S, et al. Dietary treatment with rice containing resistant starch improves markers of endothelial function with reduction of postprandial blood glucose and oxidative stress in patients with prediabetes or newly diagnosed type 2 diabetes. Atherosclerosis. 2012;224:457–64. doi:https://doi.org/10.1016/j.atherosclerosis
- Hu R, Li Y, Lv Q, Wu T, Tong N. Acarbose monotherapy and type 2 diabetes prevention in eastern and western prediabetes: an ethnicity-specific meta-analysis. Clin Ther. 2015;37(8):1798–812. doi:https://doi.org/10.1016/j.clinthera
- Fabiani R, Naldini G, Chiavarini M. Dietary patterns and metabolic syndrome in adult subjects: a systematic review and meta-analysis. Nutrients. 2019;11(9):2056. doi:https://doi.org/10.3390/nu1109
- García-Bailo B, Brenner DR, Nielsen D, Lee H-J, Domanski D, Kuzyk M, Borchers CH, Badawi A, Karmali MA, El-Sohemy A. Dietary patterns and ethnicity are associated with distinct plasma proteomic groups. Am J Clin Nutr. 2012;95(2):352–61. doi:https://doi.org/10.3945/ajcn.111.022657
- Arulselvan P, Fard MT, Tan WS, Gothai S, Fakurazi S, Norhaizan ME, Kumar SS. Role of antioxidants and natural products in inflammation. Oxid Med Cell Longev. 2016;2016:5276130. doi:https://doi.org/10.1155/2016/5276130
- Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45. doi:https://doi.org/10.1146/annurev-immunol-031210-101322
- RK, FSS, WZ. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol. 2016;29:77–89. doi:https://doi.org/10.1016/j.coph.2016.07.005
- Subbaramaiah K, Morris PG, Zhou XK, Morrow M, Du B, Giri D, Kopelovich L, Hudis CA, Dannenberg AJ. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov. 2012;2(4):356–65. doi:https://doi.org/10.1158/2159-8290.Cd-11-0241
- Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207–15. doi:https://doi.org/10.1016/s2213-8587(14)70134-2
- Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD, Guralnik JM, Longo DL. The origins of age-related proinflammatory state. Blood. 2005;105(6):2294–9. doi:https://doi.org/10.1182/blood-2004-07-2599
- Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9. doi:https://doi.org/10.1093/gerona/glu057
- Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol. 2018;9:586. doi:https://doi.org/10.3389/fimmu.2018.00586
- Peiró C, Romacho T, Azcutia V, Villalobos L, Fernández E, Bolaños JP, Moncada S, Sánchez-Ferrer CF. Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway. Cardiovasc Diabetol. 2016;15:82. doi:https://doi.org/10.1186/s12933-016-0397-2
- Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435–44. doi:https://doi.org/10.1007/s11892-013-0375-y
- Xu N, Jiang S, Persson PB, Persson EAG, Lai EY, Patzak A. Reactive oxygen species in renal vascular function. Acta Physiol (Oxf). 2020;229(4):e13477. doi:https://doi.org/10.1111/apha.13477
- Stephens JW, Brown KE, Min T. Chronic kidney disease in type 2 diabetes: implications for managing glycaemic control, cardiovascular and renal risk. Diabetes Obes Metab. 2020;22(Suppl 1):32–45. doi:https://doi.org/10.1111/dom.13942
- Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M. Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus. Compr Physiol. 2018;9(1):1–58. doi:https://doi.org/10.1002/cphy.c170040
- Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–84. doi:https://doi.org/10.1016/j.cjca.2017.12.005
- Bk KE, Id O, Hn L, Id O, Ms H. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients. 2018;10:1499 doi:https://doi.org/10.3390/nu10101499
- Jl S, FB. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535:56–64. doi:https://doi.org/10.1038/nature18846
- Roshanravan N, Alamdari NM, Jafarabadi MA, Mohammadi A, Shabestari BR, Nasirzadeh N, Asghari S, Mansoori B, Akbarzadeh M, Ghavami A, et al. Effects of oral butyrate and inulin supplementation on inflammation-induced pyroptosis pathway in type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Cytokine. 2020;131:155101. doi:https://doi.org/10.1016/j.cyto.2020.155101